Manufacturing

Western Wisconsin is no longer just for farmers and tourists - it is going high tech. As Inside Wisconsin columnist Tom Still explains, the spill over from the Twin Cities explains some of the growth, but a commitment to regional cooperation, which should be adopted...

Wisconsin would like to lure a Georgia biotechnology company involved in stem cell research, but that may turn out to be easier said than done. The University of Georgia is trying to beat officials and investors here to the punch and give Aruna Biomedical...

Ushering in a new age, DEMO Letter columnist Chris Shipley recently addressed the DEMO 2007 Conference in California, and once again reminded those in attendance that technology consumers are in charge. Not that they needed much reminding, as nearly 70 new products on display provided...

Governor Jim Doyle's 2007-09 budget proposal will include $2 million for a proposed venture capital center that seeks to connect entrepreneurs with sources of capital and serve as a point of entry for investors that want to deal in Wisconsin. The venture capital center, a...

Next Generation columnist Tony DiRomualdo is back after a holiday hiatus, and he is taking note of the latest episode of “CEOs Gone Wild” featuring Bob Nardelli, who was asked to leave Home Depot. A bitter pill to swallow, he writes, but $210 million worth...

Beware of data center companies that don't want to show off their goods, opines columnist James Carlini. If they don't want to open their facilities to prospective customers, it begs the following questions: what are they hiding or what are they missing? Make sure you...

Third Wave Technologies will receive $10.75 million in cash as part of a settlement with Stratagene Corp. The two companies, which also agreed to resolve future disputes through arbitration or licensing agreements, have been sparring over who has the right to commercialize certain molecular...

It's not a done deal yet, but a Georgia stem cell company is contemplating a move to Wisconsin. Aruna Biomedical, which was spun out of research developed at the University of Georgia, will move to Wisconsin if it can find additional backing from angel investors....